News (81)

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results GL
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results GL
Xilio Therapeutics : Corporate Update Call PU
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program BU
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing GL
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program GL
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program AQ
Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference GL
Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference AQ
Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference GL
Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference AQ
Xilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, a Tumor-Activated IL-12, Further Validating the Promise of Its Tumor-Activated Immuno-Oncology Therapies GL
Xilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, a Tumor-Activated IL-12, Further Validating the Promise of Its Tumor-Activated Immuno-Oncology Therapies AQ
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results GL
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results AQ
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer GL
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer AQ
Xilio Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference GL
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results GL
Xilio Therapeutics Announces Promotion of Chris Frankenfield to Chief Operating Officer GL
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results GL
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results AQ
Xilio Therapeutics Announces Pipeline and Business Updates for the Fourth Quarter and Full Year 2022 Financial Results GL
ReFrame and IMDbPro Announce 2022 ReFrame Stamp Film Recipients BU
Xilio Therapeutics to Present at the Citi 2023 Virtual Oncology Leadership Summit GL
Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day GL
Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day AQ
Xilio Therapeutics to Host Live Virtual Program Spotlighting XTX301, a Tumor-Activated IL-12 GL
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results GL
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results AQ
Xilio Therapeutics Announces Encouraging Preliminary Phase 1 Dose-Escalation Data for XTX101, a Tumor-Selective Anti-CTLA-4, and Reports Pipeline and Business Updates and Second Quarter 2022 Financial Results GL
Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President GL
Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President GL
XILIO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer GL
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results GL
Xilio Therapeutics : Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results - Form 8-K PU
Xilio Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results GL
Xilio Therapeutics to Participate in the Cowen 42nd Annual Healthcare Conference AQ
Adagio Therapeutics : Announces David Hering Appointed Interim Chief Executive Officer - Form 8-K PU
Xilio Therapeutics to Participate in the Guggenheim 4th Annual Oncology Day AQ
Xilio Therapeutics : Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results - Form 8-K PU
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results AQ
X4 PHARMACEUTICALS, INC : Change in Directors or Principal Officers (form 8-K) AQ
X4 Pharmaceuticals, Inc. Approves Resignation of Ren? Russo as Director CI
123NextSee all

Companies (14)

BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED 1 013 M $
Logo Beijing Tong Ren Tang Chinese Medicine Company Limited

Beijing Tong Ren Tang Chinese Medicine Company Limited is a company mainly engaged in the manufacturing and sale of Chinese medicine. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Ch ...

CHINA RUNJI CEMENT INC. 78 $
Logo China Runji Cement Inc.

China Runji Cement Inc. is the owner of a cement production and distribution company in mainland China through its ownership of Anhui Province Runji Cement Co., Ltd. (Anhui Runji). Anhui Runji is a producer and distributor of cement, primarily in An Hui P ...

FEIYU TECHNOLOGY INTERNATIONAL COMPANY LTD. 59 M $
Logo Feiyu Technology International Company Ltd.

Feiyu Technology International Co., Ltd. is an investment holding company principally engaged in the development and operation of mobile games and Web games. The Company’s principal markets include both domestic market and overseas markets, including Ho ...

NAN REN LAKE LEISURE AMUSEMENT CO., LTD. 93 M $
Logo Nan Ren Lake Leisure Amusement Co., Ltd.

NAN REN Hu LEISURE AMUSEMENT CO., LTD. is a Taiwan-based company principally engaged in sports and entertainment business, as well as the provision of travel related services. The Company provides resort accommodation; leisure, conference and sports facil ...

CHINA SXT PHARMACEUTICALS, INC. 778 800 $
Logo China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals Inc is a China-based pharmaceutical company that focuses on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). The Company develops, manufactures and sells three types of TC ...

TONG REN TANG TECHNOLOGIES CO. LTD. 866 M $
Logo Tong Ren Tang Technologies Co. Ltd.

Tong Ren Tang Technologies Co Ltd is a China-based company mainly engaged in the manufacture and sale of traditional Chinese medicine products. The Company's main businesses includes the production, retail and wholesale of traditional Chinese medicine pro ...

TEN REN TEA CO., LTD. 96 M $
Logo Ten Ren Tea Co., Ltd.

Ten Ren Tea Co., Ltd. is a Taiwan-based company principally engaged in the production and distribution of tea leaves, tea sets and beverages. The Company provides specialty tea products, such as oolong tea, packaged tea products, tea gifts, tea sets, tea ...

REN - REDES ENERGÉTICAS NACIONAIS, SGPS, S.A. 1 672 M $
Logo REN - Redes Energéticas Nacionais, SGPS, S.A.

REN - Redes Energéticas Nacionais, SGPS, S.A. specializes in the operation and concession management of the Portuguese electricity transportation network. Net sales break down by activity sector as follows: - electricity (63.7%): transportation of electr ...

SANDNES SPAREBANK 199 M $
Logo Sandnes Sparebank

Sandnes Sparebank is a Norway-based savings bank, that offers a broad range of banking and investment products to retail and corporate customers. The services include daily banking activities, borrowing, personal insurance (child, death, health, disablili ...

TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED 3 281 M $
Logo Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's bus ...

TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED 3 281 M $
Logo Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's bus ...

FIRST SPONSOR GROUP LIMITED 927 M $
Logo First Sponsor Group Limited

First Sponsor Group Limited is an investment holding company. The principal activities of the subsidiaries are those relating to investment holding, property development and sales, property investment, hotel ownership and operations and provision of prope ...

CHINA YUANBANG PROPERTY HOLDINGS LIMITED 8 M $
Logo China Yuanbang Property Holdings Limited

China Yuanbang Property Holdings Limited is a Guangzhou-based property developer. The Company is engaged in the business of sale and lease of properties. The Company is focused on the development of residential and commercial properties, focusing primaril ...

SHAKARGANJ LIMITED 16 M $
Logo Shakarganj Limited

Shakarganj Limited is a Pakistan-based manufacturer of food products, biofuel and textiles. The Company transforms renewable crops, such as sugarcane and cotton into value added products including refined sugar, biofuel and textiles, among others. Its seg ...


12Next

Insiders

Picture Francoise Russo
Francoise Russo

Currently, Francoise Russo is Chief Information Officer at Tabcorp Holdings Ltd. In the past she was Global Chief Information Officer at Toll Holdings Ltd. and Regional Chief Information at British American Tobacco Australiasia Ltd.


Picture Alejandro Russo
Alejandro Russo

Presently, Alejandro Russo is Chief Financial Officer & Executive Director at B&M European Value Retail SA and Chief Financial Officer & Executive Director at Wilko Retail Ltd. He is also on the board of Ever 2010 Ltd. and Asda Supermarkets Ltd. In the past Mr. Russo held the position of Chief Financial Officer at ASDA Group Ltd.


Picture Evan Russo
Evan Russo

Currently, Evan L. Russo is Chief Financial Officer at Lazard Ltd. and Chief Financial Officer of Lazard Group LLC (a subsidiary of Lazard Ltd.). Mr. Russo is also on the board of inStream Solutions LLC. In his past career he occupied the position of Attorney at Milbank LLP.


Picture Todd Russo
Todd Russo

Todd J.
Russo
currently works at Buckeye Partners LP, as Chief Executive Officer, South Texas Gateway Terminal LLC, as Chief Executive Officer, The Mann Center for the Performing Arts, as Director, Buckeye GP LLC, as Secretary, Senior Vice President & General Counsel from 2014, and VTTI BV, as Member-Supervisory Board.


Picture Fidelma Russo
Fidelma Russo

Ms. Fidelma Russo is a Senior Vice President at VMware, Inc. and an Independent Director at SBA Communications Corp. She is on the Board of Directors at SBA Communications Corp. and National Center for Women & Information Technology. Ms. Russo was previously employed as a Trustee by Mass Technology Leadership Council, Inc., a Chief Technology Officer & Executive VP by Iron Mountain, Inc., an Independent Member-Supervisory Board by Wolters Kluwer NV, a Senior Vice President & General Manager by EMC Corp., a Chief Operating Officer by SEPATON, Inc., a Vice President-Adaptive Infrastructure by Hewlett-Packard Co., and a Senior Vice President-Network Storage & Software by Sun Microsystems, Inc. She received her undergraduate degree from the University College Cork and a graduate degree from Boston University.


Picture Carl Russo
Carl Russo

Carl E.
Russo
is the founder and currently serves as the Chairman of Calix, Inc., a company founded in 1999.
He previously held the position of President & Chief Executive Officer at Cerent Corp.
in 1999.
Mr. Russo also served as a Director at Xirrus LLC, Alliance for Telecommunications Industry Solutions, and VITAL Network Services, Inc. Additionally, he held the position of Vice President-Optical Strategy at Cisco Systems, Inc. in 2002.
Prior to that, Mr. Russo was the Chief Operating Officer at Xircom, Inc. from 1995 to 1998.
He also held senior positions at Network Systems and AT&T Paradyne.
Mr. Russo was a Member-Managers Board at Swarthmore College.


Picture René Russo
René Russo

Founder of Adagio Therapeutics, Inc., René Russo presently holds the position of Chairman of Adagio Therapeutics, Inc. and President, Chief Executive Officer & Director at Xilio Therapeutics, Inc. Dr. Russo is also on the board of Celsius Therapeutics, Inc. and X4 Pharmaceuticals, Inc. (former President, Chief Executive Officer & Director). In her past career Dr. Russo was Director at Arsanis, Inc. and Vice President-Global Medical Affairs at Cubist Pharmaceuticals LLC. René Russo received a doctorate and an undergraduate degree from Rutgers Business School.


Picture Michael Russo
Michael Russo

Presently, Michael Paul Russo is Chief Technology Officer for Shift4 Payments, Inc. In his past career Mr. Russo held the position of Controller at MICROS Systems, Inc. Mr. Russo received an undergraduate degree from James Madison University and an MBA from Loyola University Maryland, Inc.


Picture Patricia Russo
Patricia Russo

Patricia Fiorello Russo is a businessperson who has been the head of 8 different companies and presently is Independent Chairman for Hewlett-Packard Enterprise Co. She is also Member of The Conference Board, Inc., Member of The Economic Club of New York and Member of The Business Council and on the board of 6 other companies. In her past career she held the position of Lead Independent Director at Howmet Aerospace, Inc., President & Chief Operating Officer for Eastman Kodak Co., Chairman & Chief Executive Officer at Lucent Technologies, Inc., Chairman at Avaya, Inc., Chief Executive Officer & Director at Nokia of America Corp., Chief Executive Officer at Alcatel Lucent SA and Chairman at Partnership for Drug-Free Kids. Ms. Russo received an undergraduate degree from Georgetown University.


Picture Roberto Russo
Roberto Russo

Roberto Russo is currently the Chief Legal & Compliance Officer at CNH Industrial NV.
He previously worked as the Director & Managing Director at Iveco Group NV in 2021.
Before that, he held positions as Senior Counsel at Fiat SpA, General Counsel at Fiat Industrial SpA, and Member of the Italian Bar Association.
Mr. Russo graduated from the London School of Economics & Political Science and the University of Turin in 1984.


Picture Tommaso di Russo
Tommaso di Russo

Tommaso di Russo is Chief Financial Officer & Head-Strategy at Banca Generali SpA. In the past he held the position of Head-Planning Department at Fideuram - Intesa Sanpaolo Private Banking SpA. He received an undergraduate degree from Sapienza University of Rome.



Picture Leslie Russo
Leslie Russo

Leslie Russo is currently a member of the Health Care Compliance Association and the Society for Human Resource Management.
Previously, she worked as the Vice President of Human Resources and Compliance at NAPA Management Services Corp.
from 2006 to 2018.
She also held the position of Vice President of Human Resources and Compliance at North American Partners in Anesthesia LLP and Senior Vice President of Operations at Health Plus Management LLC.
Russo earned an undergraduate degree and an MBA from Jacksonville State University.



Picture Augustus J. Russo
Augustus J. Russo

Augustus J.
Russo
is currently the Chief Creative Officer at AMI Entertainment Network LLC.
Previously, he worked as a Creative Director at Merit Industries, Inc. Russo received an undergraduate degree from The Pennsylvania State University.


Picture Carol P. Russo
Carol P. Russo

Carol P.
Russo
currently works as a Director at Miami Lighthouse For The Blind & Visually Impaired, Inc.


Picture Stuart Russo
Stuart Russo

Mr. Stuart Russo is Capital Advisor at HGGC LLC.
Mr. Russo received his Bachelor of Science Degree in Business Administration from the Roth School of Business, CW Post College of Long Island University in 1971.
He also attended the New York University Graduate School of Business Administration.





Picture Max Russo
Max Russo

Max Russo was the owner of Outsourcing Perú SAC.




Picture James Michael Russo
James Michael Russo

Mr. James M.
Russo is a Founder & Chief Investment Strategist at Altrius Capital Management, Inc. Mr. Russo founded Altrius Capital Management in 1997 and serves as Chief Investment Strategist and Portfolio Manager for the firm's income based investment strategies.
Mr. Russo was previously employed as a Founder, President, CEO & Chief Compliance Officer by Altrius Institutional Asset Management LLC and a Naval Aviator by United States Marine Corps.
He received his undergraduate degree from United States Naval Academy.



Picture Dee Dee Russo
Dee Dee Russo

Dee Dee Russo currently works at Saul Centers, Inc., as Investor Relations Contact.


Picture Brian Russo
Brian Russo

Brian J.
Russo
worked as a Principal at UBS Securities LLC.
He was also an Analyst at Criterion Research Group LLC from 2004 to 2006.
Additionally, he served as a Research Analyst at Ladenburg Thalmann & Co., Inc. (Broker).
Russo held the position of Principal at Broadwall Capital LLC and KBR Capital Markets LLC.
He also worked as an Analyst at Sidoti & Co. LLC.
Russo completed his undergraduate degree at Tulane University (Louisiana) in 1990.


Picture Anthony Russo
Anthony Russo

Anthony Russo is a Director, Accounting and Operations at Avista Capital Partners.
Mr. Russo joined Avista Capital Partners in 2007 and is a Certified Public Accountant.
Prior to joining Avista, Mr. Russo was a Senior Auditor at Eisner LLP.
Mr. Russo received a B.S.
in Accounting from the University at Albany.



Picture Nicholas Russo
Nicholas Russo

Nicholas B.
Russo
is currently a Managing Director at PNC Erieview Capital.
Previously, he worked as a Principal at Western Reserve Partners LLC.
He completed his undergraduate degree at the University of Mount Union.





Picture Peter Russo
Peter Russo

Mr. Peter Russo is an Advisor at Axia Partners LP, a Director at Boston University, and an Advisor at Axia Capital Partners LLC.
Mr. Russo is an Entrepreneur-in Residence and the Director of the Entrepreneurial Management Institute at the Boston University School of Management.
Prior to joining the faculty at BU, Professor Russo served as the CEO of Data Instruments.
He also serves as advisor and board member for a number of commercial and not-for-profit organizations.
Mr. Russo received his MBA degree from Harvard University in 1980 and a BS degree from the Montclair State University in 1974.








Picture Lari Russo
Lari Russo

Lari Russo currently works as a Vice President of Finance at Cold Spring Harbor Laboratory, Inc.


Picture Mark R. Russo
Mark R. Russo

Mark R.
Russo
currently works as a Chief Operating Officer & SVP-Operations at Access Television Network, Inc.






Picture Robert Russo
Robert Russo

Robert Russo served as the Chief Information Officer & Senior Vice President at Maidenform Brands LLC.
Prior to that, he obtained an undergraduate degree from State University of New York College at Cortland and an MBA from Pace University.


Picture Vince Russo
Vince Russo

Vince Russo worked as a Sales Manager-Special Projects at Xplornet Communications, Inc.












Picture Paul Russo
Paul Russo

Paul R.
Russo
is currently the Group Chief Executive Officer & Director at KCB Group Plc, the Director at National Bank of Kenya Ltd., and a Director at KCB Bank Uganda Ltd.
and KCB Insurance Agency Ltd.
He previously worked as the Group Regional Business Director at KCB Group Plc from 2014 to 2020.
He also held positions such as Head-Human Resources at Absa Group Ltd.
from 2013 to 2014, Manager-Compensation & Benefits at Kenya Breweries Ltd.
from 2000 to 2003, Head-Human Resources at Absa Bank Tanzania Ltd., Chief Human Resources Officer at Sidian Bank Ltd.
in 2006 and 2007, Receiver Manager at Chase Bank Kenya Ltd., Head-Human Capital at Pricewaterhousecoopers(Kenya) from 2007 to 2008, and Manager-Human Resources at Unga Holdings Ltd.
He obtained his undergraduate degree from Moi University and an MBA from Strathmore Business School.


Picture Dan Russo
Dan Russo

Daniel Joseph Russo is currently working as a Portfolio Manager at Potomac Fund Management, Inc. He has previously worked as a Principal at Needham & Co. LLC, Susquehanna International Group LLP, and as a Trading Associate at Banc of America Specialist, Inc. He has an undergraduate degree from Long Island University and an MBA from Gabelli School of Business.




Picture Jack Russo
Jack Russo

Jack Russo is the founder of Florence Venture Partners LLC, which was founded in 2012.
He is currently a Director at RiskIQ, Inc., Netswitch, Inc., and a Member at The State Bar of California.
He is also the Managing Partner at Entrepreneur Law Group LLP and Computerlaw Group LLP, both of which he founded.
He previously served on the Board of Directors at Securant Technologies, Inc. from 1997 to 2002.
Mr. Russo has an MBA from The Trustees of Columbia University in The City of New York, a Bachelor's degree from Brooklyn College, and completed undergraduate and graduate degrees from City University of New York.
He also has a graduate degree from UCLA School of Law, an MBA from Berkeley Law University of California, and an MBA from Columbia Business School.






Picture Enrico Russo
Enrico Russo

Enrico Russo is currently a Director at BioDue SpA and a Partner at H.
S.
Srl (Bologna) and Bottega De’ Medici SRL.
He completed his undergraduate degree at Università degli Studi di Napoli Federico II in 2003.
























Picture Giovanni Russo
Giovanni Russo

Giovanni Russo currently works at Prattville Machine & Tool Co., Inc., as President & Chief Executive Officer.


Picture Al Russo
Al Russo

Al Russo currently holds a position as Treasurer & Trustee at Cancer Support Community of Central New Jersey.








Picture Pasquale Russo
Pasquale Russo

Pasquale Russo is currently the President of Chef's Choice Cash & Carry Food Distributor, Inc. He was previously an Independent Non-Executive Director at Bonifiche Ferraresi SpA Società Agricola from 2010 to 2013.


No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW